Influence of G-CSF and EPO on Associative Learning and Motor Skills

NCT00298597 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2009-04-23

No results posted yet for this study

Summary

In the study we want to prove whether the subcutaneous application of granulocyte-stimulating factor (G-CSF) and erythropoetin (EPO) influence associative learning and/or motor skills of patients, who suffer from chronic stroke or amyotrophic lateral sclerosis. The study hypothesis is that G-CSF and EPO improve associative learning and/or motor skills.

Conditions

Interventions

DRUG

granulocyte - colony stimulating factor (G-CSF)

DRUG

erythropoetin (EPO)

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Wolf Rüdiger Schäbitz, MD · Department of Neurology, University Hospital of Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00298597 on ClinicalTrials.gov